Cargando…
P488: SAFETY AND EFFICACY OF VENETOCLAX PLUS “7 + 3” CHEMOTHERAPY IN NEWLY DIAGNOSED AML
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428801/ http://dx.doi.org/10.1097/01.HS9.0000968860.46119.b8 |
| _version_ | 1785090557332160512 |
|---|---|
| author | Mantzaris, Ioannis Goldfinger, Mendel Levitz, David Fedorov, Kateryna Munoz, Annemarie Chambers, Nicole Fehn, Karen Dhawan, Aradhika Victor, Joel Shah, Nishi Shastri, Aditi Kornblum, Noah Sica, Alejandro Gritsman, Kira Cooper, Dennis Kim, Mimi Verma, Amit K. Steidl, Ulrich Feldman, Eric Konopleva, Marina |
| author_facet | Mantzaris, Ioannis Goldfinger, Mendel Levitz, David Fedorov, Kateryna Munoz, Annemarie Chambers, Nicole Fehn, Karen Dhawan, Aradhika Victor, Joel Shah, Nishi Shastri, Aditi Kornblum, Noah Sica, Alejandro Gritsman, Kira Cooper, Dennis Kim, Mimi Verma, Amit K. Steidl, Ulrich Feldman, Eric Konopleva, Marina |
| author_sort | Mantzaris, Ioannis |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428801 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104288012023-08-17 P488: SAFETY AND EFFICACY OF VENETOCLAX PLUS “7 + 3” CHEMOTHERAPY IN NEWLY DIAGNOSED AML Mantzaris, Ioannis Goldfinger, Mendel Levitz, David Fedorov, Kateryna Munoz, Annemarie Chambers, Nicole Fehn, Karen Dhawan, Aradhika Victor, Joel Shah, Nishi Shastri, Aditi Kornblum, Noah Sica, Alejandro Gritsman, Kira Cooper, Dennis Kim, Mimi Verma, Amit K. Steidl, Ulrich Feldman, Eric Konopleva, Marina Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428801/ http://dx.doi.org/10.1097/01.HS9.0000968860.46119.b8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Mantzaris, Ioannis Goldfinger, Mendel Levitz, David Fedorov, Kateryna Munoz, Annemarie Chambers, Nicole Fehn, Karen Dhawan, Aradhika Victor, Joel Shah, Nishi Shastri, Aditi Kornblum, Noah Sica, Alejandro Gritsman, Kira Cooper, Dennis Kim, Mimi Verma, Amit K. Steidl, Ulrich Feldman, Eric Konopleva, Marina P488: SAFETY AND EFFICACY OF VENETOCLAX PLUS “7 + 3” CHEMOTHERAPY IN NEWLY DIAGNOSED AML |
| title | P488: SAFETY AND EFFICACY OF VENETOCLAX PLUS “7 + 3” CHEMOTHERAPY IN NEWLY DIAGNOSED AML |
| title_full | P488: SAFETY AND EFFICACY OF VENETOCLAX PLUS “7 + 3” CHEMOTHERAPY IN NEWLY DIAGNOSED AML |
| title_fullStr | P488: SAFETY AND EFFICACY OF VENETOCLAX PLUS “7 + 3” CHEMOTHERAPY IN NEWLY DIAGNOSED AML |
| title_full_unstemmed | P488: SAFETY AND EFFICACY OF VENETOCLAX PLUS “7 + 3” CHEMOTHERAPY IN NEWLY DIAGNOSED AML |
| title_short | P488: SAFETY AND EFFICACY OF VENETOCLAX PLUS “7 + 3” CHEMOTHERAPY IN NEWLY DIAGNOSED AML |
| title_sort | p488: safety and efficacy of venetoclax plus “7 + 3” chemotherapy in newly diagnosed aml |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428801/ http://dx.doi.org/10.1097/01.HS9.0000968860.46119.b8 |
| work_keys_str_mv | AT mantzarisioannis p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT goldfingermendel p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT levitzdavid p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT fedorovkateryna p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT munozannemarie p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT chambersnicole p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT fehnkaren p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT dhawanaradhika p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT victorjoel p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT shahnishi p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT shastriaditi p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT kornblumnoah p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT sicaalejandro p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT gritsmankira p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT cooperdennis p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT kimmimi p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT vermaamitk p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT steidlulrich p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT feldmaneric p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml AT konoplevamarina p488safetyandefficacyofvenetoclaxplus73chemotherapyinnewlydiagnosedaml |